Omnia SanaPlant Comparison
Purple coneflower vs Blackcurrant
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Purple coneflower and Blackcurrant: they share 6 indicated uses (arthritis / joint pain, cold & flu, immune support, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Purple coneflower | Blackcurrant | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Blackcurrant |
| Cold & flu | 1/10 | 5/10 | Stronger for Blackcurrant |
| Immune support | 1/10 | 5/10 | Stronger for Blackcurrant |
| Infection (general) | 1/10 | 5/10 | Stronger for Blackcurrant |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Blackcurrant |
| Skin irritation | 1/10 | 5/10 | Stronger for Blackcurrant |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Lipophilic alkamides are considered key immunomodulatory and anti-inflammatory constituents, particularly concentrated in the root.
Antioxidant phenolic compounds contributing to the plant's immunomodulatory activity.
Water-soluble polysaccharides associated with immune-stimulating activity, particularly from the aerial parts.
Give the berries their deep colour and are the principal antioxidant constituents.
The fruit is exceptionally rich in vitamin C, contributing to its traditional cold/flu use.
The seed oil is a well-known plant source of the omega-6 fatty acid GLA.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from antiviral action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from diuretic action
inferred from diuretic action
Safety, Cautions & Contraindications
Generally considered safe, but caution advised for those with autoimmune conditions. Not recommended for long-term use (more than 8 weeks continuously).
Duke (2002) rates echinacea as +++ — among the most thoroughly documented herbal immunostimulants. It notes experimental and clinical evidence for immunostimulant, antiviral, and anti-inflammatory activities. Multiple species have been studied (E. purpurea, E. angustifolia, E. pallida), and Duke emphasizes that species identification in commercial products is often unreliable. Commission E approves E. purpurea for supporting immune function during colds and flu. Dose: 900 mg standardized extract daily in acute use; use should be limited to 8 weeks continuous. Contraindicated in autoimmune diseases (MS, lupus, HIV/AIDS), tuberculosis, and with immunosuppressive drugs (cyclosporine) (Duke, 2002).
Fruit (berries) • Generally safe as food for most people; adverse effects mainly GI discomfort or allergy in sensitive individuals. • If using high-dose extracts, use extra caution with blood-thinners/anticoagulants (evidence is not definitive, but polyphenol-rich supplements are often treated cautiously in practice). Leaf (folium) • EMA classifies blackcurrant leaf as a traditional herbal medicinal product (not “well-established use”): minor joint pain and urinary-tract flushing. • Typical label cautions (EMA-style): not recommended <18, avoid if you have edema due to impaired heart/kidney function, and seek medical advice if urinary symptoms persist/worsen. • Pregnancy/lactation: food use is fine, but medicinal leaf dosing is generally used cautiously due to limited robust safety data. Seed (seed oil) • Usually well tolerated, but may cause GI upset in some people. • Caution with anticoagulants/antiplatelet drugs (PUFA supplements are often used cautiously here). • Note: some trials explored maternal/infant contexts, but that does not automatically mean “recommended in pregnancy” outside medical supervision.
Duke (2002) rates blackcurrant fruit highly (+++), with evidence for anti-inflammatory, angioprotective, and antioxidant activities. Ribes nigrum extracts showed the richest anthocyanin and polyphenol content in antioxidant studies, outperforming many other common berries. Clinical use is supported for diarrhea, colds, and flu. The high vitamin C and anthocyanin content underpin its vasoprotective effects. The fruit is treated as food-grade medicine and is classified as generally safe (Duke, 2002).
External Ids
Botanical Description
Robust perennial herb with a basal rosette of coarse, hairy, lance-shaped leaves and tall, sturdy flowering stems. Each stem bears a single large, daisy-like flower head with drooping (reflexed), rose-purple to pink ray florets surrounding a prominent, spiny, orange-brown central cone of disc florets.[4]
Deciduous shrub (Grossulariaceae), 1-2 m tall, aromatic when the leaves are crushed. Leaves are palmately lobed (3-5 lobes), toothed, with resinous glands on the underside. Small, greenish-white to dull purple, bell-shaped flowers are borne in drooping racemes, followed by clusters of glossy black berries.
Habitat
Native to the tallgrass prairies, open woodland and dry meadows of central and eastern North America; widely cultivated worldwide as a garden and medicinal plant.[4]
Native to central and northern Europe and Siberia, growing in damp woodland, fens, riverbanks and hedgerows; widely cultivated commercially as a fruit crop in cool-temperate climates.
Harvesting
The flower heads are picked as they open, in summer; the root is dug in autumn from plants at least two to three years old, when its content of bioactive alkamides and caffeic acid derivatives is highest, then cleaned and dried.[4]
Berries are hand- or machine-harvested in mid- to late summer once fully ripe and black. Leaves are gathered in late spring to early summer, before flowering fades, for the medicinal leaf preparation. Seed oil is cold-pressed from the seeds after juicing.
Traditional Uses
Echinacea root was widely used by Native American peoples as a remedy for infections, wounds, snakebite and toothache, and entered nineteenth-century Eclectic medicine as a broad anti-infective. It remains best known today, in standardised aerial-part or root extracts, as a supportive remedy for preventing and shortening the common cold and supporting immune function.[1, 4]
Blackcurrant has a long northern-European food-medicine tradition: the vitamin-C- and anthocyanin-rich berries have traditionally been used for colds, flu and general vitality, while the leaf has an official EU traditional-use registration for minor joint pain and as a urinary-tract flush, and the seed oil is valued as a source of gamma-linolenic acid (GLA). Modern research confirms broad antioxidant, anti-inflammatory, immunomodulatory and vasoprotective activity across the fruit, leaf and seed oil.[11, 12, 13]
Preparations
Fresh-pressed juice or standardised extract of the aerial parts or root, taken as tablets, drops or capsules at the first sign of a cold; the best-studied clinical form.
Dosage
Clinical trials for the common cold commonly use around 300-900 mg of standardised extract daily, started at the first sign of symptoms and continued for up to 7-10 days; continuous use beyond about 8 weeks is not recommended. Educational reference only, not a prescription.
EMA-style traditional-use guidance for the leaf suggests roughly 2-4 g dried leaf per cup as an infusion, up to three times daily, for short-term joint or urinary support (not recommended under 18, or with fluid retention linked to heart/kidney disease). Berries and juice are food-safe at normal dietary amounts. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
References & Sources
- Karsch-Völk, M., Barrett, B., Kiefer, D., Bauer, R. et al (2014) 'Echinacea for preventing and treating the common cold', Cochrane Database of Systematic Reviews, 2(2), pp. CD000530. doi:10.1002/14651858.CD000530.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD000530.pub3 - Kamin, W., Seifert, G., Zwiauer, K., Bonhoeffer, J. et al (2025) 'Phytotherapy for acute respiratory tract infections in children: a systematically conducted, comprehensive review', Frontiers in Pediatrics, 13, pp. 1423250. doi:10.3389/fped.2025.1423250 Meta-analysis / review
https://doi.org/10.3389/fped.2025.1423250 - Fashner, J., Ericson, K. and Werner, S (2012) 'Treatment of the common cold in children and adults', American Family Physician, 86(2), pp. 153-159. Available at: https://pubmed.ncbi.nlm.nih.gov/22962927/ Traditional / reference
https://pubmed.ncbi.nlm.nih.gov/22962927/ - Manayi, A., Vazirian, M. and Saeidnia, S (2015) 'Echinacea purpurea: Pharmacology, phytochemistry and analysis methods', Pharmacognosy Reviews, 9(17), pp. 63-72. doi:10.4103/0973-7847.156353 Meta-analysis / review
https://doi.org/10.4103/0973-7847.156353 - Burlou-Nagy, C., Banica, F., Jurca, T., Vicas, L.G., Marian, E., Muresan, M.E., Bacskay, I., Kiss, R., Feher, P. and Pallag, A (2022) 'Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review', Plants, 11(9), pp. 1244. doi:10.3390/plants11091244 Meta-analysis / review
https://doi.org/10.3390/plants11091244 - Hall, H., Fahlman, M.M. and Engels, H.J (2007) 'Echinacea purpurea and mucosal immunity', International Journal of Sports Medicine, 28(9), pp. 792-797. doi:10.1055/s-2007-964895 Randomized trial
https://doi.org/10.1055/s-2007-964895 - Ross, S.M (2016) 'Echinacea purpurea: A Proprietary Extract of Echinacea purpurea Is Shown to be Safe and Effective in the Prevention of the Common Cold', Holistic Nursing Practice, 30(1), pp. 54-57. doi:10.1097/HNP.0000000000000130 Meta-analysis / review
https://doi.org/10.1097/HNP.0000000000000130 - Hudson, J.B (2011) 'Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases', Journal of Biomedicine & Biotechnology, 2012, pp. 769896. doi:10.1155/2012/769896 Meta-analysis / review
https://doi.org/10.1155/2012/769896 - Mishima, S., Saito, K., Maruyama, H., Inoue, M., Yamashita, T., Ishida, T. and Gu, Y (2004) 'Antioxidant and immuno-enhancing effects of Echinacea purpurea', Biological & Pharmaceutical Bulletin, 27(7), pp. 1004-1009. doi:10.1248/bpb.27.1004 Preclinical
https://doi.org/10.1248/bpb.27.1004 - Saunders, P.R., Smith, F. and Schusky, R.W (2007) 'Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections', Canadian Journal of Physiology and Pharmacology, 85(11), pp. 1195-1199. doi:10.1139/Y07-103 Clinical study
https://doi.org/10.1139/Y07-103 - Micheli, L., Maggini, V., Ciampi, C., Gallo, E., Bogani, P., Fani, R., Pistelli, L., Ghelardini, C., Di Cesare Mannelli, L., De Leo, M. and Firenzuoli, F (2022) 'Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy', Phytotherapy Research, 37(5), pp. 1911-1923. doi:10.1002/ptr.7709 Preclinical
https://doi.org/10.1002/ptr.7709 - Gholami, M., Amri, J., Pazhoohan, S. and Sadegh, M (2021) 'Anticonvulsive and anti-epileptogenesis effects of Echinacea purpurea root extract, an involvement of CB2 receptor', Journal of Complementary & Integrative Medicine, 19(4), pp. 879-886. doi:10.1515/jcim-2020-0219 Preclinical
https://doi.org/10.1515/jcim-2020-0219 - Awortwe, C., Bruckmueller, H., Kaehler, M. and Cascorbi, I (2021) 'Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters', Molecular Pharmaceutics, 18(4), pp. 1622-1633. doi:10.1021/acs.molpharmaceut.0c01075 Preclinical
https://doi.org/10.1021/acs.molpharmaceut.0c01075 - Perry, N.B., van Klink, J.W., Burgess, E.J. and Parmenter, G.A (1997) 'Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers', Planta Medica, 63(1), pp. 58-62. doi:10.1055/s-2006-957605 Preclinical
https://doi.org/10.1055/s-2006-957605 - Linde, K., Barrett, B., Wölkart, K., Bauer, R. and Melchart, D (2006) 'Echinacea for preventing and treating the common cold'. Traditional / reference
https://scholar.google.com/scholar?q=Echinacea%20for%20preventing%20and%20treating%20the%20common%20cold - Sharma, M., Schoop, R., Suter, A. and Schoop, W (2010) 'The possibility of prophylactic treatment of streptococcal pharyngotonsillitis with a standardized Echinacea preparation', 29(8), pp. 1025--1035. Traditional / reference
https://scholar.google.com/scholar?q=The%20possibility%20of%20prophylactic%20treatment%20of%20streptococcal%20pharyngotonsillitis%20with%20a%20standardized%20Echinacea%20preparation - World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Gorski, J.C., Huang, S.M., Pinto, A., Hamman, M.A., Hilligoss, J.K., Zaheer, N.A., Desai, M., Miller, M. and Hall, S.D (2004) 'The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo', Clinical Pharmacology and Therapeutics, 75(1), pp. 89-100. doi:10.1016/j.clpt.2003.09.013 Clinical study
https://doi.org/10.1016/j.clpt.2003.09.013
- Lee, Y., Pham, T.X., Bae, M., Hu, S. and others (2019) 'Blackcurrant (Ribes nigrum) Prevents Obesity-Induced Nonalcoholic Steatohepatitis in Mice', Obesity (Silver Spring), 27(1), pp. 112-120. doi:10.1002/oby.22353 Preclinical
https://doi.org/10.1002/oby.22353 - da Costa, P., Schetinger, M.R.C., Baldissarelli, J., Stefanello, N. and others (2024) 'Blackcurrant (Ribes nigrum L.) improves cholinergic signaling and protects against chronic scopolamine-induced memory impairment in mice', Journal of Psychopharmacology, 38(12), pp. 1170-1183. doi:10.1177/02698811241273776 Preclinical
https://doi.org/10.1177/02698811241273776 - Nanashima, N., Horie, K., Yamanouchi, K., Tomisawa, T. and others (2020) 'Blackcurrant (Ribes nigrum) Extract Prevents Dyslipidemia and Hepatic Steatosis in Ovariectomized Rats', Nutrients, 12(5), pp. 1541. doi:10.3390/nu12051541 Preclinical
https://doi.org/10.3390/nu12051541 - Lee, Y. and Lee, J.Y (2019) 'Blackcurrant (Ribes nigrum) Extract Exerts an Anti-Inflammatory Action by Modulating Macrophage Phenotypes', Nutrients, 11(5), pp. 975. doi:10.3390/nu11050975 Preclinical
https://doi.org/10.3390/nu11050975 - Lappi, J., Raninen, K., Vakevainen, K., Karlund, A. and others (2020) 'Blackcurrant (Ribes nigrum) lowers sugar-induced postprandial glycaemia independently and in a product with fermented quinoa: a randomised crossover trial', British Journal of Nutrition, 126(5), pp. 708-717. doi:10.1017/S0007114520004468 Randomized trial
https://doi.org/10.1017/S0007114520004468 - Horie, K., Maeda, H., Nanashima, N. and Oey, I (2021) 'Potential Vasculoprotective Effects of Blackcurrant (Ribes nigrum) Extract in Diabetic KK-Ay Mice', Molecules, 26(21), pp. 6459. doi:10.3390/molecules26216459 Preclinical
https://doi.org/10.3390/molecules26216459 - Nanashima, N., Horie, K., Kitajima, M., Takamagi, S. and others (2021) 'Hypocholesterolemic Effect of Blackcurrant (Ribes nigrum) Extract in Healthy Female Subjects: A Pilot Study', Molecules, 26(13), pp. 4085. doi:10.3390/molecules26134085 Clinical study
https://doi.org/10.3390/molecules26134085 - Horie, K., Nanashima, N., Maeda, H., Tomisawa, T. and others (2021) 'Blackcurrant (Ribes nigrum L.) Extract Exerts Potential Vasculoprotective Effects in Ovariectomized Rats, Including Prevention of Elastin Degradation and Pathological Vascular Remodeling', Nutrients, 13(2), pp. 560. doi:10.3390/nu13020560 Preclinical
https://doi.org/10.3390/nu13020560 - Oczkowski, M (2021) 'Health-promoting effects of bioactive compounds in blackcurrant (Ribes nigrum L.) berries', Roczniki Panstwowego Zakladu Higieny, 72(3), pp. 229-238. doi:10.32394/rpzh.2021.0174 Meta-analysis / review
https://doi.org/10.32394/rpzh.2021.0174 - Vagiri, M., Conner, S., Stewart, D., Andersson, S.C. and others (2015) 'Phenolic compounds in blackcurrant (Ribes nigrum L.) leaves relative to leaf position and harvest date', Food Chemistry, 172, pp. 135-142. doi:10.1016/j.foodchem.2014.09.041 Preclinical
https://doi.org/10.1016/j.foodchem.2014.09.041 - Gopalan, A., Reuben, S.C., Ahmed, S., Darvesh, A.S., Hohmann, J. and Bishayee, A (2012) 'The health benefits of blackcurrants', 3(8), pp. 795--809. doi:10.1039/c2fo30058c Randomized trial
https://doi.org/10.1039/c2fo30058c - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Watson, A.W., Haskell-Ramsay, C.F., Kennedy, D.O., Dodd, F.L., Wightman, E.L. and Reay, J.L (2015) 'Acute supplementation with blackcurrant extracts modulates cognitive functioning and inhibits monoamine oxidase-B in healthy young adults', 54(3), pp. 505--513. Traditional / reference
https://scholar.google.com/scholar?q=Acute%20supplementation%20with%20blackcurrant%20extracts%20modulates%20cognitive%20functioning%20and%20inhibits%20monoamine%20oxidase-B%20in%20healthy%20young%20adults - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.